Philadelphia, United States
Allevi by 3D Systems, founded in 2014 and headquartered in the United States, is a pioneering company in the fields of Biotechnology, VR/AR, and 3D Printing. With a compelling slogan, "Versatile and easy-to-use 3D bioprinters and bioinks. Bring your work to life," Allevi is at the forefront of the biofabrication revolution, empowering researchers to tackle complex challenges such as curing diseases, testing novel drugs, and addressing organ shortages.
Allevi's product line includes state-of-the-art 3D bioprinters, software, and bioinks designed for flexibility and user-friendliness. The company has established a global customer base, serving hundreds of research labs. This extensive reach and the versatility of its products position Allevi as a leader in its market.
In their latest financial move, Allevi secured a $1.00M investment through an Initial Coin Offering on 01 November 2019, with backing from The Provco Group. This financial commitment underscores investor confidence in Allevi's innovative capabilities and future growth potential.
